Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

7.1K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.1K
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

137
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
137
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

449
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
449

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Method for quality-assessing excised human corneal buttons for nanoparticle visualization.

Applied optics·2025
Same author

20 nm nanoparticles trigger calcium influx to endothelial cells <i>via</i> a TRPV4 channel.

Biomaterials science·2025
Same author

Distinct Inflammatory Programs Underlie the Intramuscular Lipid Nanoparticle Response.

ACS nano·2024
Same author

Nanoparticle-Based Strategies for Managing Biofilm Infections in Wounds: A Comprehensive Review.

ACS omega·2024
Same author

Differential effect of gold nanoparticles on cerebrovascular function and biomechanical properties.

Physiological reports·2023
Same author

Sickle cell disease: Contributing factors and radiological assessments.

Journal of the National Medical Association·2023

Related Experiment Video

Updated: Sep 13, 2025

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
07:15

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis

Published on: October 20, 2013

9.4K

Inflammatory microenvironment-responsive MR imaging contrast agents.

Stephen Paige1, Jessica Lukac1, Ian Stender1

  • 1Department of Biomedical Engineering, University of Vermont, Burlington, VT, USA.

Nanomedicine (London, England)
|July 30, 2025
PubMed
Summary
This summary is machine-generated.

New activatable MRI contrast agents offer enhanced detection of inflammation. These smart agents respond to specific inflammatory triggers, improving disease diagnosis and treatment monitoring.

Keywords:
Activatable MR contrast agentsenzymesinflammationpHreactive oxygen species

More Related Videos

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
13:21

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Published on: July 21, 2011

15.1K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

Related Experiment Videos

Last Updated: Sep 13, 2025

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
07:15

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis

Published on: October 20, 2013

9.4K
Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
13:21

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Published on: July 21, 2011

15.1K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

Area of Science:

  • Molecular imaging
  • Biomedical engineering
  • Radiology

Background:

  • Inflammation is a key indicator in many diseases.
  • Traditional MRI lacks sensitivity for dynamic biochemical processes.
  • Activatable contrast agents are needed to overcome MRI limitations.

Purpose of the Study:

  • To review recent advancements in activatable MRI contrast agents.
  • To highlight their molecular design and activation mechanisms.
  • To discuss their potential in diagnosing and monitoring inflammatory diseases.

Main Methods:

  • Literature search of PubMed and Google Scholar (2000-2025).
  • Focus on activatable MR imaging contrast agents, redox-responsive nanoparticles, and inflammatory imaging.
  • Analysis of molecular design, activation mechanisms, and preclinical validation.

Main Results:

  • Development of smart contrast agents that respond to inflammatory triggers (pH, ROS, enzymes).
  • Demonstrated potential for localized signal enhancement in inflammatory conditions.
  • Preclinical validation shows promise for improved diagnostic accuracy and therapeutic monitoring.

Conclusions:

  • Activatable MRI contrast agents represent a significant advancement in molecular imaging of inflammation.
  • These agents can improve disease stratification and treatment response assessment.
  • Further optimization for clinical translation regarding stability, safety, and performance is crucial.